BeOne Medicines (ONC)
353.83
0.00 (0.00%)
Upcoming Events
Latest Headlines
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens on Serial Innovation
September 15, 2026 5:31 AM - StreetInsider
Form 4 BeOne Medicines Ltd. For: Sep 08 Filed by: Wang Xiaodong
September 10, 2026 4:50 PM - SEC Filing
BeOne Medicines (ONC) PT Raised to $415 at Barclays
September 10, 2026 5:06 AM - StreetInsider
Form 4 BeOne Medicines Ltd. For: Aug 25 Filed by: Wu Xiaobin
August 27, 2026 5:13 PM - SEC Filing
FDA approves BeOne's Tevimbra combo for HER2+ stomach cancer
August 25, 2026 10:40 AM - StreetInsider
BeOne Medicines Announces U.S. FDA Approval for TEVIMBRA-Based Regimen for First-Line HER2+ GEA
August 25, 2026 10:40 AM - BizWire
BeOne Medicines renews CLL drug access deal for low-income nations
August 18, 2026 6:00 AM - StreetInsider
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
August 18, 2026 6:00 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Aug 11 Filed by: Lee Chan Henry
August 13, 2026 8:55 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Aug 10 Filed by: OYLER JOHN
August 12, 2026 5:53 PM - SEC Filing
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
August 10, 2026 6:00 AM - BizWire
BeOne Medicines (ONC) PT Raised to $405 at Morgan Stanley
August 6, 2026 8:50 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $454 at TD Cowen
August 6, 2026 8:07 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $418 at Truist Securities
August 6, 2026 7:21 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $430 at Guggenheim
August 6, 2026 6:44 AM - StreetInsider
BeOne Medicines (ONC) PT Lowered to $450 at RBC Capital
August 6, 2026 6:43 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $405 at Citizens
August 6, 2026 6:31 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $407 at Barclays
August 6, 2026 4:18 AM - StreetInsider
Form 4 BeOne Medicines Ltd. For: Aug 03 Filed by: Rosenberg Aaron
August 5, 2026 5:16 PM - SEC Filing
BeOne Medicines Announces Second Quarter 2026 Financial Results and Business Updates
August 5, 2026 6:00 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Jul 30 Filed by: Lee Chan Henry
August 3, 2026 5:18 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jul 22 Filed by: Lee Chan Henry
July 24, 2026 4:51 PM - SEC Filing
BeOne Medicines (ONC) PT Raised to $425 at JPMorgan
July 23, 2026 7:39 AM - StreetInsider
BeOne Medicines adds $300M to New Jersey facility, topping $1B total
July 23, 2026 6:01 AM - StreetInsider
BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines
July 23, 2026 6:00 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Jul 20 Filed by: OYLER JOHN
July 22, 2026 5:03 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jul 17 Filed by: OYLER JOHN
July 17, 2026 5:36 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jul 15 Filed by: OYLER JOHN
July 17, 2026 5:31 PM - SEC Filing
BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
July 17, 2026 6:01 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Jul 14 Filed by: OYLER JOHN
July 14, 2026 9:27 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jul 10 Filed by: OYLER JOHN
July 14, 2026 9:25 PM - SEC Filing
BeOne Medicines (ONC) PT Lowered to $403 at Barclays
July 14, 2026 5:11 AM - StreetInsider
Jefferies Upgrades BeOne Medicines (ONC) to Buy
July 13, 2026 2:19 AM - StreetInsider
Jefferies Upgrades BeOne Medicines (ONC) to Buy
July 13, 2026 2:19 AM - StreetInsider
Form 4 BeOne Medicines Ltd. For: Jul 08 Filed by: Lee Chan Henry
July 10, 2026 4:44 PM - SEC Filing
BeOne Medicines (ONC) PT Raised to $451 at RBC Capital
July 7, 2026 7:59 AM - StreetInsider
BeOne Medicines (ONC) PT Raised to $416 at Truist Securities
July 7, 2026 7:08 AM - StreetInsider
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens on Phase 3 Results
July 1, 2026 4:41 AM - StreetInsider
BeOne's Brukinsa cuts lymphoma progression risk by 43% in trial
June 30, 2026 6:00 AM - StreetInsider
BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
June 30, 2026 6:00 AM - BizWire
Form 4 BeOne Medicines Ltd. For: Jun 23 Filed by: Wu Xiaobin
June 25, 2026 5:15 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 23 Filed by: OYLER JOHN
June 25, 2026 5:15 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 23 Filed by: Wang Lai
June 25, 2026 5:15 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 16 Filed by: Wu Xiaobin
June 18, 2026 5:20 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 16 Filed by: OYLER JOHN
June 18, 2026 5:20 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 16 Filed by: Wang Lai
June 18, 2026 5:19 PM - SEC Filing
Form 4 BeOne Medicines Ltd. For: Jun 16 Filed by: Lee Chan Henry
June 18, 2026 5:19 PM - SEC Filing
BeOne Medicines (ONC) Reiterated at Market Outperform by Citizens on New Data Release
June 17, 2026 4:24 AM - StreetInsider
Full Article List
